Annals of Internal Medicine · 1975 · 119 citations · 69 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceBacteriologyMedical MicrobiologyAnaerobic BacteriologyAntibiotic ResistanceAntimicrobial Agent SelectionAntimicrobial TherapyEmpiric Antimicrobial TherapySurgical Infection ManagementAnaerobic Bacterial InfectionsAnaerobic Infection TreatmentAnaerobic Soft Tissue InfectionsBacteroides SpeciesCephalosporin TherapyClindamycin TherapyGenital InfectionsPenicillin Resistance
Anaerobic infections are reviewed with emphasis on management. Most anaerobic pulmonary infections respond to penicillin G, even when Bacteroides fragilis (penicillin-resistant) is present. Clindamycin is suitable in penicillin-sensitive patients. Intraabdominal infections have a complex flora usually involving anaerobes, especially B. fragilis. It is desirable to use antimicrobial therapy to cover potential pathogens of all types. Surgical drainage and debridement are extremely important considerations. Anaerobic bacteria were found in 72% of 200 patients with female genital tract infections and were the exclusive isolates in 30%. Surgical therapy is primary, but antimicrobial and anticoagulant therapy are also important. A variety of soft-tissue infections involve anaerobes. Surgery is the major therapeutic approach. Anaerobic endocarditis is uncommon but may be difficult to manage. Chloramphenicol is ordinarily the drug of choice for brain abscess. New antimicrobial agents, which are under investigation and are promising, include new penicillins, new cephalosporins, new tetracyclines, and metronidazole.
69
Clindamycin-Associated Colitis
Francis J. Tedesco · Annals of Internal Medicine · 1974 · 610 citations
HEMOLYTIC STREPTOCOCCUS GANGRENE
Frank L. Meleney · Archives of Surgery · 1924 · 591 citations
Sherwood L. Gorbach, John G. Bartlett · New England Journal of Medicine · 1974 · 423 citations
Life Sciences, Biology, Microbiology +15